Metal–organic frameworks (MOFs)
have gained considerable
attention as drug delivery platforms over the past decade owing to
their tunable physiochemical properties, biodiversity, and capability
to encapsulate sizable active compound loadings. Nevertheless, many
fundamental properties pertaining to MOFs’ pharmacokinetic
performances as drug carriers have been poorly investigated. One such
property is the relationship between the MOF metal center solubility
and drug release rate. In this study, we investigated this relationship
within the M-MOF-74 family by impregnating 30 or 50 wt % curcumin
on either Mg-, Ni-, Zn-, or Co-MOF-74. The drug delivery performance
of the materials was assessed in phosphate buffered saline solution
by high-performance liquid chromatography over a time period of 0–24
h. From these experiments, it was determined that the 30 wt % curcumin
loading led to increased drug delivery and kinetics compared to the
50 wt % loading regardless of the metal center, as the lower drug
concentration did not hinder diffusion from the MOF pores. As such,
the optimal curcumin loading within the M-MOF-74 family was concluded
to be greater than 30 wt % but less than 50 wt %. These experiments
also revealed that using Mg-MOF-74 as a drug carrier produced a twofold
enhancement in the release rate from 0.15 to 0.30 h1/2 compared
to the other three metal centers, where Mg-MOF-74’s improved
pharmacokinetics were attributed to the increased group II Mg solubility
compared to Ni, Co, or Zn transition metals. On the basis of these
findings, it was concluded that to promote rapid pharmacokinetics,
it is essential to use MOFs with more soluble metal centers to promote
dissolution of the nanocarrier. While this study focused on M-MOF-74,
we expect that this conclusion has implications to other crystallites
as well.